The US Food and Drug Administration (FDA) has released a final guidance document with immediate effect advising sponsors on ...
Scientists have taken a giant leap forward with the development of tiny microneedles designed to detect subtle but critical ...
Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult ...
Synthetic” and “natural” are largely useless terms. But not “semisynthetic.” It’s a real word that describes a critical ...
The model is already live with early pharma partners Amgen and AstraZeneca. An AstraZeneca-sponsored Phase 2 trial is ...
Executive Orders and Policy Updates - In the end of 2025 and the first quarter of 2026, the Trump administration and federal ...
Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...
Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.
The data published in NEJM reflect outcomes in the PDAC cohort from the RMC-6236-001 trial (NCT05379985), an open-label, multicenter Phase 1/2 trial evaluating daraxonrasib monotherapy in patients ...
A Bristol Myers Squibb plant that makes cancer drugs was the only manufacturer in the U.S. recognized for innovation by the ...
Men’s Health spoke to Novo Nordisk's Thomas Kruse and Jesper Lau, the two chemists responsible for discovering ...
US drug pricing policy and Congressional Budget Office (CBO) model of the Build Back Better Act examining pharmaceutical R&D ...